Submit the keyword or topic you are searching for

  1. Home
  2. Politics
  3. Lupin shares rise on US launch of kidney drug Tolvaptan; $200 million revenue seen by FY26
Politics

Lupin shares rise on US launch of kidney drug Tolvaptan; $200 million revenue seen by FY26

featured-image

The drug, a copy of Jynarque, could add up to $200 million in annual revenue by FY26, strengthening Lupin’s foothold in complex generics and supporting its margin recovery strategy..

My Protein Germany

Myprotein UK

Menkind UK

Top News

What Region In America Tends To Have The Cheapest Gas Prices (And Is There A Reason Why?)

Gas prices can vary quite a bit from state to state, but one...

13 years on, high court allows Bolivians to fly back home

'Thunderbolts' tops global box office with $162 million haul; 'Hit 3' makes it into Top 10 list with $800K collection

Sports News | Ajinkya Rahane Surpasses Chris Gayle to Become 9th Highest IPL Run Getter

Related Posts

post-thumbnail
Politics

Biden Criticizes Trump's Approach to Ukraine as 'Modern-Day Appeasement'

post-thumbnail
Politics

Operation Sindoor: India Kills 80+ Terrorists in Precision Strikes

post-thumbnail
Politics

Why Trump is Not Leading Efforts to Ease India-Pakistan Crisis

post-thumbnail
Politics

Trump May Rename Persian Gulf During Middle East Visit

post-thumbnail
Politics

Trump Hints at Major Trade Deal with Key Ally

post-thumbnail
Politics

Man who crashed car through Jennifer Aniston’s gate facing felony stalking and vandalism charges

post-thumbnail
Politics

Adu-Boahene’s ‘eye-opening’ revelation of an ‘opposition party’ taking GHC 8.3m from him tickles Ghanaians

post-thumbnail
Politics

Ratmalana: An international airport without modern navigational and landing aids